BMO Capital analyst Andrew Strelzik downgraded Bloomin' Brands (BLMN) to Underperform from Market Perform and lowered his price target for the shares to $18 from $23. African Swine Fever will likely create a "meaningful, multi-year upswing" in protein prices, and Bloomin' is among the restaurants most at risk, Strelzik tells investors in a research note. He believes margin pressure from African Swine Fever creates downside risk to earnings and notes that his 2020 earnings estimates for the company are nearly 10% below consensus. Strelzik also downgraded Chipotle Mexican Grill (CMG) to Underperform this morning for a similar rationale.